Cargando…
Liver X receptors induce antiproliferative effects in basal‐like breast cancer
Liver X receptors (LXRs) are nuclear transcription factors important in the regulation of cholesterol transport, and glucose and fatty acid metabolism. The antiproliferative role of LXRs has been studied in a variety of malignancies and may represent a therapeutic opportunity in cancers lacking targ...
Autores principales: | Haugen, Mads Haugland, von der Lippe Gythfeldt, Hedda, Egeland, Eivind Valen, Svartdal Normann, Lisa, Pandya, Abhilash D., Vedin, Lise‐Lotte, Juell, Siri, Tenstad, Ellen, Øy, Geir Frode, Kristian, Alexandr, Marangoni, Elisabetta, Sørlie, Therese, Steffensen, Knut, Mælandsmo, Gunhild Mari, Engebraaten, Olav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552888/ https://www.ncbi.nlm.nih.gov/pubmed/37341140 http://dx.doi.org/10.1002/1878-0261.13476 |
Ejemplares similares
-
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
por: Pettersen, Solveig, et al.
Publicado: (2023) -
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023) -
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
por: Normann, Lisa Svartdal, et al.
Publicado: (2022) -
Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4
por: Prasmickaite, Lina, et al.
Publicado: (2018) -
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
por: Normann, Lisa Svartdal, et al.
Publicado: (2021)